Nice

News

UK politicians to grill Vertex CEO over CF price drug row

The CEO of Vertex Pharmaceuticals is to give evidence before influential UK politicians on Thursday, who are investigating the ongoing row over the price of cystic fibrosis drugs in England

Views & Analysis

Market access roundup: UK HTA shakeups as Brexit fears deepe...

With a Brexit deal still out of sight, there have been intensified warnings in the UK about potential disruptions to medicine supplies that could follow a no-deal scenario.

News

Price cut unlocks NICE nod for Perjeta in post-surgery breas...

Roche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer from recurring after surgery, at the third attempt.

News

NICE launches scientific advice tie-up with Canadian agency

The UK’s cost-effectiveness regulator NICE and the its counterpart in Canada have launched a new collaboration to offer parallel scientific advice to the life sciences industry.

News

Vertex calls for changes to NICE as CF drug profits soar

Vertex has revealed financial figures that are likely to go down well with investors, but not patients in the UK who are eligible to receive the revolutionary drugs like Orkambi yet are bei

News

NICE approves Novartis' CAR-T therapy for diffuse large B-ce...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments.

UK politicians to grill Vertex CEO over CF price drug row

Market access roundup: UK HTA shakeups as Brexit fears deepe...

Price cut unlocks NICE nod for Perjeta in post-surgery breas...

NICE launches scientific advice tie-up with Canadian agency

Vertex calls for changes to NICE as CF drug profits soar

NICE approves Novartis' CAR-T therapy for diffuse large B-ce...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Nice

Editor's Picks